Global Regenerative Trade

GOB and Global Biomedikal announcing the official launch

Global OrthoBiologic Inc.(GOB) together with its Turkish partner Global Biomedikal is pleased to announce the official launch of the Magellan BMAC kit in two of the largest cities in Turkey – Ankara and Istanbul.  Medical trainings and meetings were organized in front of key doctors and university professors.

The first procedure was performed in Hacettepe University in Ankara by the head of the university, ProfessorMahmut NedimDoral, MD.  GOB scientific officer Dr. Dzihan Abazovic assisted Prof. Doral’s team and Associate Professor, Dr. GaziHuri during the nonunion case. The team aspirated bone marrow from the patient’s tibia and processed itwiththe Magellan® Autologous Platelet Separator. After the procedure,the GOB team was invited to join Shoulder Club International( Thisisa great opportunity for Global OrthoBiologic Inc to become part of another international society and to confirm its importance in connecting the most innovative therapiesworldwide.

The official launch of the Magellan in Istanbul was held in the MedipolUniversity. This private university is highly respected in Turkey with the most innovative therapies launched in their Operating Rooms.Associate Prof. Ahmet Murat Bülbül MD is the head of the orthopedic team in Medipoland he alsomanages several OR simultaneously.GOB Team succeeded to impress him and captured all his attention with the easy noninvasive bone marrow aspiration draw from the tibia. He noted that the Magellan aspiration was easier, smoother and faster than the jamshidi version and he didn’t even had time to drink his cup of tea!

After the procedures, Global Biomedikal was invited by Medipol University to further explore ways to use the Magellan BMAC.

Dr.Bülbül and his team invited GOB to discuss a potential clinical study that would prove that the BMAC aspirated from the tibia outpatient using a local anesthetic will be a beneficial and more cost effective therapy for OA than available currently. This will give GOB the foundation to implement this therapy as an option to other procedures offered for OA.

Next stop on our Turkish visit was LIV Hospital for a meeting with GOB scientific board member Professor Erdal Karaoz.The main point of the discussion was the great opportunity to acquire the MBSI project in Switzerland with his active facility. During the meeting, our partners from Global Biomedikal received an invitation from the orthopedic department ofLiv Hospital to implement and promote the Magellan BMAC.

Finally, the GOB team visited our physician advisory board member Dr. Tahsin Beyzadeoglu. We discussed the opportunity for Global Biomedikal to start performing surgeries in the American Hospital in order to test the reimbursement process for the Magellan BMAC with the private insurances in Turkey. Dr. Beyzadeoglu agreed to assist Global Biomedikal to promote and implement our products in the American Hospital and Acibadem. He is willing to rent their OR in order to perform surgeries with the Magellan® Autologous Platelet Separator.

Dr. Abazovic discussed with Dr. Beyzadeoglu his innovative treatment for cartilage repair with fully autologous product.  Dr. Beyzadeouglu accepted the invitation to participate in such a treatment next August in Belgrade.

About Global OrthoBiologic Inc.

Global OrthoBiologic Inc., based in Miami Florida, develops, markets, and globally distributes new and innovative products in the field of Regenerative Medicine. Global OrthoBiologic Inc. was established to promote and distribute groundbreaking medical technologies for use in therapies that significantly enhance the body’s natural healing ability. During the last decade, the company has developed extensive experience in the most advanced medical device industries and technologies. Global OrthoBiologic Inc. consults not only with startup biotech and medical technology companies, but also with mature companies that wish to better develop their international business. In the past several years, the company’s emphasis has been focused exclusively on Regenerative Medicine, such as stem cell technologies, products, and therapies. Global OrthoBiologic Inc. has built a comprehensive network of experts and country distributors in Europe, South America, Middle East, Asia, and Australia. Global OrthoBiologic Inc. has additional sales offices in Sofia, Bulgaria and Dubai, UAE, as well as a distribution center in Amsterdam, Netherlands.

About Global Biomedikal

Global Biomedical Product Portfolio

  • Innovative Technologies
  • Regenerative Therapies(Cell-Based)
  • Treatments for chronic diseases
Vivostat Logo


The uniqueness of the Vivostat® system is a novel patented biotechnological process that enables reliable and reproducible preparation of autologous Fibrin Sealant or Platelet Rich Fibrin (PRF®) without using cryoprecipitation and without the need for a separate thrombin component.